← FDA Drug Approvals (Drugs@FDA)
DOBUTAMINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 1993-10-19
Drug application
- FDA Application #
ANDA074206- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOBUTAMINE HYDROCHLORIDE
- Generic name
- Dobutamine Hydrochloride
- Active ingredients
- DOBUTAMINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- TEVA PARENTERAL
- First approval
- 1993-10-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown